NCT02755259View on ClinicalTrials.gov

Acute Hemodynamic Effect of Acetazolamide in Pulmonary Hypertension

PHASE2/PHASE3CompletedINTERVENTIONAL
Enrollment

33

Participants

Timeline

Start Date

January 1, 2017

Primary Completion Date

April 5, 2019

Study Completion Date

April 5, 2019

Conditions
Hypertension, Pulmonary
Interventions
DRUG

Acetazolamide

DRUG

Placebo

Trial Locations (1)

8091

University Hospital Zurich, Zurich

All Listed Sponsors
lead

University of Zurich

OTHER

NCT02755259 - Acute Hemodynamic Effect of Acetazolamide in Pulmonary Hypertension | Biotech Hunter | Biotech Hunter